Loading...
Rituximab
India Pharmaceutical Trade Intelligence
Who Supplies Rituximab to India from TAIWAN
India's rituximab imports from TAIWAN total $2.2K across 2 shipments from 1 foreign suppliers. ABNOVA TAIWAN CORPORATION leads with $2.2K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BI BIOTECH INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for rituximab — a concentrated sourcing relationship with select suppliers from TAIWAN.
Top foreign suppliers (TAIWAN) — Ranked by import value
ABNOVA TAIWAN CORPORATION is the leading Rituximab supplier from TAIWAN to India, with import value of $2.2K across 2 shipments. The top 5 suppliers — ABNOVA TAIWAN CORPORATION — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (TAIWAN)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ABNOVA TAIWAN CORPORATION | $2.2K | 2 | 100.0% |
Showing top 1 of 1 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from TAIWAN)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BI BIOTECH INDIA PRIVATE LIMITED | $2.2K | 2 | 100.0% |
Import Statistics
- Import Value
- $2.2K
- Shipments
- 2
- Foreign Suppliers
- 1
- Indian Buyers
- 1
- Avg. Shipment
- $1.1K
Other Rituximab Import Origins
Frequently Asked Questions — Rituximab Imports from TAIWAN
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Rituximab suppliers from TAIWAN to India?
The top Rituximab suppliers from TAIWAN to India include ABNOVA TAIWAN CORPORATION. The leading supplier is ABNOVA TAIWAN CORPORATION with import value of $2.2K USD across 2 shipments. India imported Rituximab worth $2.2K USD from TAIWAN in total across 2 shipments.
QHow much Rituximab does India import from TAIWAN?
India imported Rituximab worth $2.2K USD from TAIWAN across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Rituximab from TAIWAN?
The main Indian buyers of Rituximab sourced from TAIWAN include BI BIOTECH INDIA PRIVATE LIMITED. The largest buyer is BI BIOTECH INDIA PRIVATE LIMITED with $2.2K in imports across 2 shipments.
QWhat is the total value of Rituximab imports from TAIWAN to India?
The total value of Rituximab imports from TAIWAN to India is $2.2K USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: TAIWAN to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Rituximab.
- 2.Supplier/Buyer Matching: 1 foreign suppliers from TAIWAN and 1 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $2.2K aggregated from 2 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists